All Events
Age related Macular Degeneration: What's on the Horizon

27/02/2025

18:30 - 19:30

CPD Points For Attending This Event: 1

Webinar

This event has already taken place.

This webinar, presented by Dr. Yasmine Abdalla, Consultant Ophthalmologist and Uveitis Service Lead at the University Hospitals of Derby and Burton NHS Foundation Trust, provided a comprehensive overview of Age-Related Macular Degeneration (AMD). The session covered the latest research, diagnostic approaches, and emerging treatments for both dry and wet AMD, including cutting-edge technologies like gene therapy and novel drug delivery systems.

Key Topics Covered:

  • Definition and Types of AMD
  • Types of Drusen (Soft, Cuticular, Sub-Retinal)
  • Risk Factors and Beckman Classification
  • Stages of Dry AMD (AREDS Grading System)
  • Emerging Technologies - AI in AMD Diagnosis
  • Current and Emerging Treatments for Dry and Wet AMD
  • Gene Therapy and Cutting-Edge Innovations

Speakers

Dr. Yasmine Abdallah, M.S, FRCOphth.,

Consultant Ophthalmologist, Uveitis Service Lead, University Hospitals of Derby and Burton NHS Trust. U.K.

Age-related macular degeneration (AMD) advances through early, intermediate, and late stages. While anti-VEGF therapies are effective for wet AMD, there are no approved treatments currently available for dry AMD in the UK. Emerging approaches, including sustained-release anti-VEGF, gene therapy, and complement inhibitors, offer hope for dry AMD.

Slides available here

Topics

AMD - Definition Drusen Types of Drusen Soft Drusen Cuticular Drusen Sub-retinal drusenoid deposits Prevalence Risk factors Beckman classification Stages of Dry AMD - AREDS Grading System Prognostic factors 2023 Euretina clinical trends survey Diagnosis A.I in AMD Assessing AMD Microperimetry OCT CAM Classification system Treatment - Dry AMD Syfovre (pegcetacoplan) Izervay (avacincaptad) Photobiomodulation Neo-vascular AMD GASS Classification of CNV Treatment - Antivegf Avastin Lucentis Eyelea Faricimab Brolucizumab Ranibizumab Faricimab Aflibercept Port delivery system - Ranibizumab Zifibancimig Intravitreal drug delivery implants - Axitinib Vorolanib Suprachoroidal drug delivery - CLS AX Axitinib phase 2 ODYSSEY Subretinal drug delivery via PPV Gene therapy Stereotactic radiotherapy

About the Speaker:

Dr. Yasmine Abdalla, M.S, FRCOphth., is a Consultant Ophthalmologist and Uveitis Service Lead at the University Hospitals of Derby and Burton NHS Foundation Trust. She is a fellow of the Royal College of Ophthalmologists with extensive experience in managing complex uveitis and retinal conditions.

Sponsors

Other Events

How do we minimise stents in Coronary intervention? Drug coated balloons: Emerging and Expanding Indications

24/04/2025 - 18:30 - 19:30

Rated Doctor